Active substance
Triamterene
- US FDA 3
- US price lines 2
- Safety 3
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DYRENIUM | 50MG; 100MG | capsule · oral | ADVANZ PHARMA | Prescription | 10 Aug 1964 |
| TRIAMTERENE | 50MG; 100MG | capsule · oral | TP ANDA HOLDINGS | Prescription | 19 Aug 2019 |
| TRIAMTERENE | 50MG; 100MG | capsule · oral | BIOCON GENERICS | Prescription | 6 Jul 2022 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | TRIAMTERENE 100 MG CAPSULE | $7.04719 | per EA | 23 Sep 2026 |
| US NADAC | TRIAMTERENE 50 MG CAPSULE | $5.97533 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 20 Aug 2020 DYAZIDE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions - US FDA 20 Aug 2020 MAXZIDE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions - US FDA 20 Aug 2020 MAXZIDE-25 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions
Combinations containing Triamterene
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.